Leukemia Research
Volume 29, Issue 6 , Pages 605-606, June 2005

The rationale engineering of BCR/ABL blockers: an answer to STI571 acquired resistance in leukemia treatment

Department of Molecular Genetics, University of Lodz, Banacha12/16, 90-237 Lodz, Poland

Received 24 November 2004 published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(05)00026-3

doi:10.1016/j.leukres.2004.11.019

Leukemia Research
Volume 29, Issue 6 , Pages 605-606, June 2005

Article Tools